At The Christ Hospital in Cincinnati, a 70-year-old man who had already endured three open-heart surgeries had blood flow restored to a hard-to-reach part of his heart without going under the knife ...

Anthony Palumbo and Charles Goulding analyze Boston Scientific’s US$14.5 billion acquisition of Penumbra, showing how additive manufacturing can accelerate thrombectomy and neurovascular innovation ...

BIRMINGHAM, AL, UNITED STATES, February 10, 2026 / EINPresswire.com / — Vascular & Interventional Specialists of America (VISA), specializing in minimally invasive treatments for health conditions ...

HEFEI CITY, ANHUI PROVINCE, CHINA, February 12, 2026 /EINPresswire.com/ -- The global temperature sensing industry has ...

An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, according to results presented today at the EAPCI Summit 2026.

Among large-cap U.S. MedTech companies, Boston Scientific BSX and Abbott ABT continue to attract significant investor focus.

The procedure was performed by interventional cardiologist David Lasorda, DO; cardiac surgeon Walter McGregor, MD; and Georgios Lygouris, MD, imaging cardiologist, using a recently FDA-approved heart ...

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Ladies and gentlemen, thank you for standing by. My name is Colby, and I will be your conference ...

An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, according to results presented at the EAPCI Summit 2026. Primary ...

Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven by Digital Insulin Pens and Pumps Transforming Diabetes Care, Says a 2026 Mordor Intelligence Report ...

Catheter Precision shifts focus to electrophysiology by divesting atherectomy catheter technologies to an unnamed strategic ...